Medicare Enrolled

Dr. Ali Shirvani, MD

Urology Physician · Carrollton, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4325 N JOSEY LN STE 206, Carrollton, TX 75010
2149158515
In practice since 2005 (20 years)
NPI: 1528054046 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shirvani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shirvani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shirvani

Dr. Ali Shirvani is an urology physician in Carrollton, TX, with 20 years in practice. Based on federal Medicare data, Dr. Shirvani performed 35,373 Medicare services across 2,041 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shirvani received a total of $2,650 from 29 pharmaceutical and/or device companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shirvani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 2% volume in TX$ $2,650 industry payments

Medicare Practice Summary

Medicare Utilization ↗
35,373
Medicare services
Top 2% in TX for urology physician
2,041
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,769 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection31,800$0$0
Automated urinalysis673$2$5
Office visit, established patient (20-29 min)350$63$183
Blood draw (venipuncture)293$8$17
Office visit, established patient (30-39 min)269$90$259
Bladder ultrasound after voiding265$8$22
Urine culture, bacterial colony count211$8$16
Drug injection, under skin or into muscle206$10$29
Infectious disease DNA/RNA test182$34$70
Ceftriaxone antibiotic injection161$0$1
Basic metabolic blood panel151$8$17
PSA test (prostate cancer screening)150$18$37
Urine culture, bacterial identification122$8$16
Testosterone (hormone) level, total64$25$52
Bacterial culture, aerobic52$8$16
New patient office visit (45-59 min)52$118$336
Antibiotic sensitivity test49$8$17
Injection, garamycin, gentamicin, up to 80 mg49$2$6
Yeast/candida DNA test42$34$70
Diagnostic exam of bladder and urethra using an endoscope39$187$494
New patient office visit (30-44 min)29$72$226
Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique14$34$70
Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique14$34$70
Detection test by nucleic acid for herpes virus-6, amplified probe technique14$34$70
Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique14$41$83
Detection of mycoplasma genitalium by dna or rna probe14$34$70
Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique14$34$70
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique14$34$70
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique14$34$70
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique14$34$70
Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique14$34$70
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique13$34$70
Simple bladder irrigation and/or instillation11$54$156
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,650
Total received (2018-2024)
Avg $379/year across 7 years
Bottom 46% in TX for urology physician
29
Companies
203
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,103 (79.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$548 (20.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$273
2023
$272
2022
$550
2021
$297
2020
$147
2019
$332
2018
$779

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$679
Sumitomo Pharma America, Inc.
$461
UROVANT SCIENCES INC
$242
Endo Pharmaceuticals Inc.
$220
PROCEPT BioRobotics Corporation
$125
BOSTON SCIENTIFIC CORPORATION
$95
Myovant Sciences Inc.
$91
PFIZER INC.
$87
Janssen Biotech, Inc.
$84
Dendreon Pharmaceuticals LLC
$52
Tolmar, Inc.
$50
AKRIMAX PHARMACEUTICALS, LLC
$45
Avadel Specialty Pharmaceuticals, LLC
$44
Bayer HealthCare Pharmaceuticals Inc.
$42
Olympus America Inc.
$35
AbbVie, Inc.
$30
Allergan Inc.
$28
Medtronic USA, Inc.
$28
Aytu BioScience, Inc
$27
Mission Pharmacal Company
$26
COLOPLAST CORP
$23
Augmenix, Inc.
$21
Ferring Pharmaceuticals Inc.
$21
Merck Sharp & Dohme Corporation
$20
Metuchen Pharmaceuticals
$18
Amgen Inc.
$17
Boston Scientific Corporation
$15
Blue Earth Diagnostics Limited
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
Top 3 companies account for 52.1% of total payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AQUABEAM ROBOTIC SYSTEM · Androgel · Axumin · BOTOX THERAPEUTIC · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GREENLIGHT · INTERSTIM · ImaJin · JATENZO · KEYTRUDA · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus Resection Disposables · PROVENGE · Prolia · ShockPulse - SE · SpaceOAR · Stendra · TOVIAZ · Uribel · XIAFLEX · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for a urology physician in Carrollton?
Compare urology physicians in the Carrollton area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
136
Per 100K population
14.4
County median income
$108,185
Nearest hospital
CARROLLTON REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shirvani is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shirvani experienced with testosterone injection?
Based on Medicare claims data, Dr. Shirvani performed 31,800 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shirvani receive payments from pharmaceutical companies?
Yes. Dr. Shirvani received a total of $2,650 from 29 companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shirvani's costs compare to other urology physicians in Carrollton?
Dr. Shirvani's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shirvani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →